Surgical Innovations Group PLC
30 July 2007
Press Release - final 30 July 2007
Surgical Innovations Group plc
('SI' or 'The Group')
US Distribution Agreement
Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of
innovative surgical devices, announces that it has signed a distribution
agreement with MGM Med Inc. ('MGM'), a wholesale distributor of medical and
hospital equipment, for the provision of its laparoscopic equipment to the US
market.
Under the terms of the agreement, MGM has the right to use the Surgical
Innovations ('SI') name and will promote the SI brand through its newly formed
subsidiary, Surgical Innovations US Inc. ('Surgical US').
Surgical US will become the master distributor of SI branded products in the US
and will engage with new key channel partners including surgical procedural tray
companies, major medical distributors and small independent representatives that
service more than 6,000 hospitals in the US market
The agreement incorporates a minimum sales target of US$20 million, net to SI,
over the five year term.
The agreement has already led to the appointment by Surgical US of its first
channel partner, Tri-anim Health Services, Inc. ('Tri-anim'), a leading
specialty distributor of medical and hospital equipment in the US. Tri-anim
will begin sales of SI's single use laparoscopic scissors from August 2007,
initially in the south east of the US and increasing thereafter on a regional
basis, eventually providing nationwide coverage.
Mary Meyer, President and CEO of Surgical US, said: 'The US market for single
use scissors is currently valued at over US$125 million and we see huge
potential for SI products throughout the entire US laparoscopic equipment
market.'
Graham Bowland, Finance Director of Surgical Innovations Group plc, commented:
'The creation by MGM of Surgical US provides new and exciting routes to market
for SI's products, further expanding our presence within North America. The use
of the Surgical Innovations trademark will increase our brand recognition across
the US and will support our strategy for future growth.'
- Ends -
For further information:
Surgical Innovations Group plc
Graham Bowland, Finance Director Tel: +44 (0) 113 230 7597
graham.bowland@surginno.co.uk www.sigroupplc.com
Hanson Westhouse Limited
Tim Feather / Matthew Johnson Tel: +44 (0) 113 246 2610
tim.feather@hansonwesthouse.com www.hansonwesthouse.com
Media enquiries:
Abchurch
Gareth Mead / Justin Heath Tel: +44 (0) 20 7398 7700
gareth.mead@abchurch-group.com www.abchurch-group.com
Notes to Editors:
Surgical Innovations Group plc specialises in the design and manufacture of
innovative devices for use in minimally invasive surgery and industrial markets.
The Group employs over 50 people and is headquartered in Leeds.
The Group's medical division is focused on strong international growth in two
specialist areas namely minimally invasive surgery, where products are used in
'keyhole' surgery which is more accurately known as laparoscopic surgery, and
products for autologous blood transfusion whereby a patient's own blood is
recycled.
The Group's industrial division utilises Surgical Innovations' core medical
device design expertise and technology in innovative engineering applications.
For more information, see www.sigroupplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.